Natco gets emergency use nod for Baricitinib to treat Covid without trials

In a statement, the Hyderabad headquartered pharma company said Baricitinib in combination with Remdesivir is used for the treatment of Covid-19 patients.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news